Body Contouring Devices Market Size, Share & Trends Analysis Report By Type (Noninvasive And Minimally Invasive Devices, Invasive Devices), By Application, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global body contouring devices market size was valued at USD 1,180.9 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.3% from 2022 to 2030. Body contouring devices can be invasive and non-invasive or minimally invasive, which aim to reshape an area of the body. This can be done surgically via liposuction or through less invasive methods like cryo lipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis. The main goal of body contouring procedures is to eliminate unwanted and achieve firmness in the treatment area.

However, the advent of the COVID-19 pandemic affected the overall aesthetic market. But many aesthetic professionals believe that the pandemic might most likely propel the body contouring market. According to the American Society of Plastic Surgeons, the pandemic led to an increase in the acceptance of cosmetic procedures and many women are now more inclined and interested in nonsurgical procedures than before the pandemic.

Rising cases of obesity across the globe due to unhealthy lifestyles are anticipated to drive the global market. Improved safety and efficacy of these techniques resulting in increased life expectancy are also expected to boost their demand. Initiatives, such as M&A, novel product launches, and partnerships, undertaken by major companies for product research and distribution are expected to drive the market further in the coming years.

Non-invasive fat reduction or nonsurgical fat reduction includes minimally invasive treatments that break down stubborn subcutaneous fat pockets beneath the skin. Major factors driving market growth include rising demand for body contouring treatment, as it is non-invasive and requires no downtime after completion of the procedure. SculpSure, developed by Cynosure, Inc., is a non-invasive body contouring laser device that targets and destroys around 24% of unwanted fat cells in 25 minutes.

According to WHO, obesity is a global epidemic that has tripled since 1975, and currently, about 30% of the world’s population is obese. A sedentary lifestyle is a major underlying cause of obesity, disease, and disability. Levels of physical inactivity are virtually high in all developed and developing countries. Increased urbanization has contributed immensely to the increase in sedentary lifestyles which in turn escalated the prevalence of obesity globally.

The advent of the COVID-19 pandemic had affected the overall aesthetic and beauty market. All invasive and non-invasive esthetic procedures were significantly affected amid the pandemic; this includes the body contouring market. According to Bloomberg, procedures such as non-invasive fat reduction, injection lipolysis, invasive liposuction soft tissue fillers, facelifts, eye lifts, eyelid surgeries, laser skin resurfacing, rhinoplasty, and tummy tucks decreased by 20% in the first half of 2020.

However, The International Society of Aesthetic Plastic Surgery reported that the willingness and demand for cosmetic treatments like body contouring increased drastically by the end of 2020 and reached higher than the pre-pandemic levels in 2021.

Type Insights

Non-invasive and Minimally Invasive Devices held a maximum share of 77.0% of the market in 2021. Based on the type, the market has been segmented into non-invasive & minimally invasive devices and invasive devices. In 2021, non-invasive & minimally invasive body contouring devices accounted for the largest share of the market and are expected to maintain their share during the forecast period. Entry of various products, investment by market players, and high demand for non-invasive and minimally invasive procedures due to their safe and cost-effective nature are driving the market.

Invasive body contouring procedure, Liposuction or lipolysis, has remained one of the most popular and in-demand plastic surgery procedures for body contouring and is particularly effective in removing fat in the legs, abdomen, back, arms, face, and neck. According to the American Society of Plastic Surgeons (ASPS), liposuction was the second-most carried out procedure in the U.S. after breast augmentation, with 211,067 procedural volumes in 2020.

Liposuction is considered one of the most effective procedures for body fat removal, as it can remove up to 5 liters (11 pounds) of fat from this procedure. However, with the advent of non-invasive treatments that are cost-effective and deliver the same results, the demand for liposuction has witnessed a slight decline. According to Healthline, as the procedure requires surgical intervention, its cost might be more than other procedures and this might impede the market growth.

Application Insights

The non-surgical skin tightening application segment held a significant market share of 21.1% in 2021. Based on the body contouring procedure the market has been segmented into nonsurgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others. In 2021, the Non-surgical skin tightening segment accounted for a high market share and is expected to grow at a fast rate during the forecast period. This can be attributed to the minimally invasive and non-invasiveness of the procedures and low cost as compared to an invasive procedure.

The others segment includes injectable body contouring and gastric band. Injectable body contouring can be done by FDA-approved treatment injections called Kybella. This injection contains deoxycholic acid, which is naturally produced by the body to target fat cells. Kybella is injected every month for 3 to 6 sessions and after the treatment, the body breaks down & absorbs fat cells.

Non-Surgical Skin Tightening is also expected to show significant market growth of 15.0% during the forecast period. This is because, with age, collagen increases, and elastin production in the body decreases, giving the appearance of fine lines and dull & sagging skin. Non-invasive tightening devices like Thermage, Ulthera, and Pelleve assist in stimulating collagen and elastin production by inducing laser or ultrasound energy in the target area, which gradually improves the skin's texture & tone. 

Regional Insights 

North America dominated the body contouring devices market with a share of 35.6% in 2021 and is expected to showcase a significant CAGR in the forecast period. This is attributed to the rising geriatric population, strong medical infrastructure, well-established reimbursement policies, the existence of key market players, and advancements in aesthetic body contouring procedures. Moreover, Moreover, attributes like high acceptance and openness towards body contouring treatments, and soaring appearance-conscious customer pool is likely to propel the non-invasive body contouring market in the region of North America.

APAC region is expected to witness the highest CAGR of 15.2% over the forecast period. Asian countries such as China, Japan, and India are emerging economies with well-developed healthcare infrastructure and facilities and are now more focused on leading based on R&D activities. Asian countries have been a long renowned hub for aesthetic procedures. Numerous fat reduction procedures are carried out in countries like China, South Korea, and Japan per year, cost-effective and high-quality treatment, rising disposable income, and growing obese & geriatric population are driving the market in the APAC region.

Key Companies & Market Share Insights

The market players are rapidly opting for geographical expansion, strategic collaborations, and partnerships through mergers and acquisitions in emerging and economically favorable regions. In June 2020, InMode Ltd. received Health Canada certification of Evolve Tone. This certification will make Evolve platform Canada's only, all-in-one hands-free device consisting of three unique body remodeling technologies - Tite, Trim, and Tone. Some of the players in the body contouring devices market include:

• Cynosure, Inc.

• Alma Lasers

• Allergan Plc

• Merz Pharma Gmbh

• Candela Medical Ltd.

• Solta Medical Bausch Health Companies, Inc.

• Lutronic Corporation

• InMode Ltd

• Fotona

• Sofwave Medical LTD

• Sciton Inc

• Lumenis

Body Contouring Devices Market Report Scope

Global Body Contouring Devices Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global body contouring devices market based on type, application, and region:

• Body Contouring Devices Market Outlook, by Type (Revenue, USD Million, 2018 - 2030)

  • Non-invasive and Minimally Invasive Devices

  • Invasive Devices

• Body Contouring Devices Market Outlook, by Application type (Revenue, USD Million, 2018 - 2030)

  • Nonsurgical skin Resurfacing

  • Nonsurgical skin tightening

  • Cellulite treatment

  • Liposuction

  • Others

• Body Contouring Devices Market Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE